PLUS THERAPEUTICS, INC. Common Stock Shares Outstanding

• PLUS THERAPEUTICS, INC. showed an increase of +2,251.9% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from PLUS THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2010 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 19 years of available data (2010 to 2025), PLUS THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 166.9%.
• Historical annual values: Fiscal year 2025: 138.68 million shares | Fiscal year 2024: 5.90 million shares | Fiscal year 2023: 4.44 million shares | Fiscal year 2023: 37.40 million shares | Fiscal year 2022: 2.24 million shares | Fiscal year 2021: 15.51 million shares | Fiscal year 2020: 6.75 million shares | Fiscal year 2019: 3.88 million shares | Fiscal year 2018: 296,609 shares | Fiscal year 2018: 6.20 million shares | Fiscal year 2017: 5.78 million shares | Fiscal year 2016: 21.71 million shares | Fiscal year 2016: 13.30 million shares | Fiscal year 2015: 13.00 million shares | Fiscal year 2014: 99.35 million shares | Fiscal year 2013: 71.31 million shares | Fiscal year 2012: 65.91 million shares | Fiscal year 2011: 56.59 million shares | Fiscal year 2010: 51.96 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026